{
    "title": "UK-based Indivior considers a secondary US listing as the opioid addiction treatment maker's sales surge",
    "url": "https://www.dailymail.co.uk/money/markets/article-10518419/Indivior-weighs-secondary-listing-sales-soar.html",
    "date": "2022-02-16",
    "keywords": [
        "year",
        "listing",
        "addiction",
        "treatment",
        "cent",
        "share",
        "maker",
        "indivior",
        "group",
        "growth",
        "profit",
        "quarter",
        "loss",
        "revenue",
        "marketthe",
        "rise",
        "today",
        "line",
        "newer",
        "therapy",
        "ftse",
        "company",
        "sublocade",
        "market",
        "report",
        "business",
        "inflation",
        "high",
        "invasion",
        "train",
        "article",
        "money",
        "price",
        "data",
        "boost",
        "competition",
        "drawnout",
        "revenueboss",
        "mark",
        "crossley",
        "view",
        "profile",
        "visibility",
        "topic",
        "board",
        "management",
        "intend",
        "paththe",
        "period",
        "track",
        "target",
        "worth",
        "opioid",
        "disease",
        "control",
        "prevention",
        "country"
    ],
    "category": [
        "money",
        "markets"
    ]
}